Pacesetter, Inc.
USPTO PatentsView assignee record - 754 granted patents across 60 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy).
The verdict
According to USPTO PatentsView, Pacesetter ranks #591 of 49,997 tracked US assignees by granted-patent volume, with 754 patents across 60 technology areas.
- #591
- of 49,997 US assignees by volume
- Top 1%
- by Innovation Score (66.2/100)
- 17.8
- avg claims per patent
- +16%
- grant velocity, last 5 yrs
USPTO PatentsView assignee plate
Corpus R591 · US Corporation #591 · 754 grants
GRANTS-MID · TOP-DECILE · PHOTO-FINISH · CPC-WIDE · INNOV-STRONG · CLAIMS-RICH · TYPE-USCORP · VEL-UP · BOOK-FULL
- GRANTS-MID 754 grants
- TOP-DECILE #591/49,997
- PHOTO-FINISH adidas
- CPC-WIDE A61N · 60 areas
- INNOV-STRONG 66.2/100
- CLAIMS-RICH 17.8 claims/avg
- TYPE-USCORP US Corporation
- VEL-UP +16% vel
- BOOK-FULL 10/10 fields
Nearest grant-volume peer: adidas AG (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
How Pacesetter’s 66.2 Innovation Score adds up
The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.
Innovation-score neighbourhood around Pacesetter
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- X Development · near
X Development · near
66 score
- Dana Italia S R L · near
Dana Italia S R L · near
66 score
- Pacesetter · this assignee
Pacesetter · this assignee
66 score
- Kuwait University · near
Kuwait University · near
66 score
- Rogers · near
Rogers · near
66 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows Pacesetter's Innovation Score is 66.2/100 (top 1% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Does more volume mean deeper claims for Pacesetter?
Each dot is one of Pacesetter’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Pacesetter’s own 17.8 claims/patent is ABOVE the 13.8 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.
How Pacesetter's grant cadence moved
Between 2020–2024, Pacesetter, Inc. received 374 grants versus 322 in 2015–2019 (+16% equal-window velocity, above median growth). Across complete PatentsView years, output peaked in 2023 at 88 grants and bottomed in 2017 at 50. Lead class A61N accounts for 80.8% of the portfolio across 60 subclasses. Volume neighbours: Cochlear Limited (#586) and Spigen Korea Co., Ltd. (#594).
Pacesetter's three-year grant acceleration
From 2019–2021 to 2022–2024, Pacesetter, Inc. moved from 201 to 229 grants (1.14x the prior three-year total, a multiple, not a CAGR). Among 3,296 tracked assignees with ≥100 grants and ≥20 prior-period grants, that multiple ranks #890. See the growth leaderboard.
Who files at Pacesetter's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Cochlear
Cochlear Limited
768 patents
- Mellanox
Mellanox Technologies, Ltd.
766 patents
- Mediatek Singapor…
MediaTek Singapore Pte. Ltd.
761 patents
- Hanon Systems
Hanon Systems
758 patents
- adidas
adidas AG
754 patents
- Pacesetter ◀
Pacesetter, Inc.
754 patents
- Medline Industries
Medline Industries, LP
753 patents
- Shenzhen Goodix T…
Shenzhen Goodix Technology Co., Ltd.
753 patents
- Spigen Korea
Spigen Korea Co., Ltd.
749 patents
What this shows Pacesetter holds 754 patents at rank #590, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near Pacesetter
By rank, the assignees closest to #590 in granted patent volume.
- Cochlear Limited #586 · 768 patents
- Mellanox Technologies, Ltd. #587 · 766 patents
- MediaTek Singapore Pte. Ltd. #588 · 761 patents
- Hanon Systems #589 · 758 patents
- adidas AG #591 · 754 patents
- Medline Industries, LP #592 · 753 patents
- Shenzhen Goodix Technology Co., Ltd. #593 · 753 patents
- Spigen Korea Co., Ltd. #594 · 749 patents
Leaders in A61N (Electrotherapy)
Other assignees with the most granted patents in Pacesetter's primary technology class.
- Medtronic, Inc. 2,200 in class
- Boston Scientific Neuromodulation Corporation 1,080 in class
- Cardiac Pacemakers, Inc. 1,037 in class
- Zoll Medical Corporation 556 in class
- Koniniklijke Philips N.V. 534 in class
- Varian Medical Systems, Inc. 296 in class
- Advanced Bionics AG 284 in class
- The Regents of the University of California 278 in class
Assignees with similar portfolio profiles
Two PlainPatent-derived peer sets for Pacesetter, neither rank-band nor same-CPC leaders (those blocks stay above). In A61N (Electrotherapy), Pacesetter ranks #4 of 1,943 assignees by patent count in that subclass.
Similar innovation score
Nearest assignees by Innovation Score (66 here).
Similar claim depth
Nearest assignees by average claims per patent (17.8 here).
Pacesetter's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
66 Top 1% higher than 99% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 82 | 10.9% |
| 2016 | 78 | 10.3% |
| 2017 | 50 | 6.6% |
| 2018 | 56 | 7.4% |
| 2019 | 56 | 7.4% |
| 2020 | 79 | 10.5% |
| 2021 | 66 | 8.8% |
| 2022 | 64 | 8.5% |
| 2023 | 88 | 11.7% |
| 2024 | 77 | 10.2% |
| 2025partial year | 58 | 7.7% |
Which technologies does Pacesetter, Inc. patent most?
Top 15 of 60 technology areas
Data Source
USPTO PatentsView, US granted patents 2015–2025
What to do with this data
Pacesetter, Inc.'s patent record in context - here's where to go next.
- Pacesetter, Inc.'s lead technology class is A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy), 80.8% of its portfolio - see every assignee active in that class. Explore A61N
- Ranked #591 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare Pacesetter, Inc. against Cochlear Limited, an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 66.2/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.